Aclipse Therapeutics
Phase 2Welcome to Aclipse Therapeutics Aclipse Therapeutics develops novel and highly differentiated therapeutics to treat life-threatening and severe diseases. Our approach leverages genomic, proteomic and biomarker data to develop disease-modifying drug candidates and potential biomarkers. Aclipse Therapeutics focuses on molecular pathways that regulate inflammation, cellular stress, protein misfolding. We focus on neuromuscular diseases that are strongly […]
About
Welcome to Aclipse Therapeutics Aclipse Therapeutics develops novel and highly differentiated therapeutics to treat life-threatening and severe diseases. Our approach leverages genomic, proteomic and biomarker data to develop disease-modifying drug candidates and potential biomarkers. Aclipse Therapeutics focuses on molecular pathways that regulate inflammation, cellular stress, protein misfolding. We focus on neuromuscular diseases that are strongly […]
Funding History
2Total raised: $33M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile